CTIC Annual EBIT
-$78.86 M
+$17.13 M+17.85%
31 December 2022
Summary:
As of February 5, 2025, CTIC annual earnings before interest & taxes is -$78.86 million, with the most recent change of +$17.13 million (+17.85%) on December 31, 2022. During the last 3 years, it has fallen by -$40.36 million (-104.82%).CTIC EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTIC Quarterly EBIT
-$8.37 M
+$5.00 M+37.39%
31 March 2023
Summary:
As of February 5, 2025, CTIC quarterly earnings before interest & taxes is -$8.37 million, with the most recent change of +$5.00 million (+37.39%) on March 31, 2023. Over the past year, it has increased by +$26.72 million (+76.14%).CTIC Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTIC TTM EBIT
-$52.13 M
+$26.72 M+33.89%
31 March 2023
Summary:
As of February 5, 2025, CTIC TTM earnings before interest & taxes is -$52.13 million, with the most recent change of +$26.72 million (+33.89%) on March 31, 2023. Over the past year, it has increased by +$61.88 million (+54.28%).CTIC TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTIC EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.9% | +76.1% | +54.3% |
| 3 y3 years | -104.8% | +29.6% | -30.3% |
| 5 y5 years | -103.3% | -131.8% | -35.4% |
CTIC EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +511.3% | -152.5% | +783.6% |
CTI BioPharma EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$8.37 M(-37.4%) | -$52.13 M(-33.9%) |
| Dec 2022 | -$78.86 M(-17.8%) | -$13.37 M(+14.2%) | -$78.86 M(-22.2%) |
| Sept 2022 | - | -$11.71 M(-37.3%) | -$101.39 M(-10.4%) |
| June 2022 | - | -$18.68 M(-46.8%) | -$113.20 M(-0.7%) |
| Mar 2022 | - | -$35.10 M(-2.2%) | -$114.02 M(+18.8%) |
| Dec 2021 | -$95.99 M(+86.7%) | -$35.90 M(+52.7%) | -$95.99 M(+28.2%) |
| Sept 2021 | - | -$23.52 M(+20.6%) | -$74.86 M(+20.0%) |
| June 2021 | - | -$19.50 M(+14.2%) | -$62.37 M(+10.2%) |
| Mar 2021 | - | -$17.07 M(+15.5%) | -$56.60 M(+10.1%) |
| Dec 2020 | -$51.42 M(+33.6%) | -$14.78 M(+34.2%) | -$51.42 M(+15.6%) |
| Sept 2020 | - | -$11.02 M(-19.8%) | -$44.50 M(+3.1%) |
| June 2020 | - | -$13.73 M(+15.5%) | -$43.16 M(+7.9%) |
| Mar 2020 | - | -$11.89 M(+51.3%) | -$40.00 M(+3.9%) |
| Dec 2019 | -$38.50 M(+39.4%) | -$7.86 M(-18.8%) | -$38.50 M(+31.2%) |
| Sept 2019 | - | -$9.68 M(-8.5%) | -$29.35 M(-13.8%) |
| June 2019 | - | -$10.58 M(+1.8%) | -$34.05 M(-1.0%) |
| Mar 2019 | - | -$10.39 M(-904.2%) | -$34.40 M(+24.5%) |
| Dec 2018 | -$27.62 M(-28.8%) | $1.29 M(-109.0%) | -$27.62 M(-35.4%) |
| Sept 2018 | - | -$14.38 M(+31.7%) | -$42.74 M(+7.2%) |
| June 2018 | - | -$10.92 M(+202.2%) | -$39.86 M(+73.0%) |
| Mar 2018 | - | -$3.61 M(-73.9%) | -$23.05 M(-40.6%) |
| Dec 2017 | -$38.80 M(-22.6%) | -$13.83 M(+20.2%) | -$38.80 M(+25.5%) |
| Sept 2017 | - | -$11.50 M(-295.0%) | -$30.90 M(-35.7%) |
| June 2017 | - | $5.90 M(-130.5%) | -$48.09 M(-34.4%) |
| Mar 2017 | - | -$19.36 M(+226.3%) | -$73.29 M(+46.2%) |
| Dec 2016 | -$50.13 M(-57.6%) | -$5.93 M(-79.3%) | -$50.13 M(-28.8%) |
| Sept 2016 | - | -$28.69 M(+48.6%) | -$70.44 M(-4.2%) |
| June 2016 | - | -$19.31 M(-607.3%) | -$73.52 M(-14.8%) |
| Mar 2016 | - | $3.81 M(-114.5%) | -$86.25 M(-27.1%) |
| Dec 2015 | -$118.27 M(+29.2%) | -$26.25 M(-17.4%) | -$118.27 M(-11.2%) |
| Sept 2015 | - | -$31.77 M(-0.8%) | -$133.21 M(+38.2%) |
| June 2015 | - | -$32.04 M(+13.6%) | -$96.42 M(+5.7%) |
| Mar 2015 | - | -$28.21 M(-31.5%) | -$91.21 M(-0.4%) |
| Dec 2014 | -$91.55 M(+117.9%) | -$41.19 M(-921.0%) | -$91.55 M(+129.5%) |
| Sept 2014 | - | $5.02 M(-118.7%) | -$39.88 M(-33.6%) |
| June 2014 | - | -$26.83 M(-6.0%) | -$60.11 M(+17.8%) |
| Mar 2014 | - | -$28.55 M(-372.5%) | -$51.02 M(+21.4%) |
| Dec 2013 | -$42.01 M(-58.7%) | $10.48 M(-168.9%) | -$42.01 M(-41.0%) |
| Sept 2013 | - | -$15.21 M(-14.3%) | -$71.20 M(+0.0%) |
| June 2013 | - | -$17.74 M(-9.2%) | -$71.20 M(-31.3%) |
| Mar 2013 | - | -$19.55 M(+4.5%) | -$103.65 M(+2.0%) |
| Dec 2012 | -$101.63 M(+66.1%) | -$18.71 M(+23.1%) | -$101.63 M(+11.3%) |
| Sept 2012 | - | -$15.20 M(-69.7%) | -$91.29 M(-1.5%) |
| June 2012 | - | -$50.20 M(+186.4%) | -$92.65 M(+56.3%) |
| Mar 2012 | - | -$17.52 M(+109.5%) | -$59.27 M(-3.1%) |
| Dec 2011 | -$61.20 M(-23.4%) | -$8.37 M(-49.5%) | -$61.16 M(-14.5%) |
| Sept 2011 | - | -$16.57 M(-1.5%) | -$71.53 M(+6.5%) |
| June 2011 | - | -$16.82 M(-13.4%) | -$67.15 M(-8.1%) |
| Mar 2011 | - | -$19.41 M(+3.6%) | -$73.09 M(-8.5%) |
| Dec 2010 | -$79.86 M(-9.1%) | -$18.73 M(+53.8%) | -$79.86 M(-8.3%) |
| Sept 2010 | - | -$12.18 M(-46.5%) | -$87.13 M(-14.7%) |
| June 2010 | - | -$22.76 M(-13.1%) | -$102.20 M(+5.0%) |
| Mar 2010 | - | -$26.18 M(+0.7%) | -$97.32 M(+10.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | -$87.82 M(+1.3%) | -$26.01 M(-4.6%) | -$87.95 M(+9.9%) |
| Sept 2009 | - | -$27.25 M(+52.4%) | -$80.06 M(+13.3%) |
| June 2009 | - | -$17.88 M(+6.4%) | -$70.67 M(-10.1%) |
| Mar 2009 | - | -$16.81 M(-7.2%) | -$78.58 M(-9.4%) |
| Dec 2008 | -$86.69 M(-19.9%) | -$18.12 M(+1.5%) | -$86.73 M(-14.3%) |
| Sept 2008 | - | -$17.86 M(-30.8%) | -$101.23 M(-8.8%) |
| June 2008 | - | -$25.79 M(+3.3%) | -$111.02 M(+1.4%) |
| Mar 2008 | - | -$24.96 M(-23.5%) | -$109.53 M(+1.3%) |
| Dec 2007 | -$108.17 M(+10.4%) | -$32.63 M(+18.1%) | -$108.17 M(+9.2%) |
| Sept 2007 | - | -$27.64 M(+13.8%) | -$99.05 M(+3.8%) |
| June 2007 | - | -$24.30 M(+2.9%) | -$95.44 M(+0.8%) |
| Mar 2007 | - | -$23.60 M(+0.4%) | -$94.68 M(-3.0%) |
| Dec 2006 | -$98.01 M(+118.0%) | -$23.51 M(-2.1%) | -$97.57 M(+67.9%) |
| Sept 2006 | - | -$24.02 M(+2.0%) | -$58.10 M(+104.4%) |
| June 2006 | - | -$23.54 M(-11.1%) | -$28.43 M(-20.4%) |
| Mar 2006 | - | -$26.50 M(-266.1%) | -$35.70 M(-20.6%) |
| Dec 2005 | -$44.95 M(-70.7%) | $15.95 M(+182.1%) | -$44.95 M(-55.7%) |
| Sept 2005 | - | $5.66 M(-118.4%) | -$101.55 M(-26.8%) |
| June 2005 | - | -$30.81 M(-13.8%) | -$138.69 M(-3.7%) |
| Mar 2005 | - | -$35.75 M(-12.0%) | -$143.99 M(-6.2%) |
| Dec 2004 | -$153.45 M(+25.2%) | -$40.64 M(+29.1%) | -$153.45 M(+4.3%) |
| Sept 2004 | - | -$31.48 M(-12.8%) | -$147.10 M(+1.2%) |
| June 2004 | - | -$36.12 M(-20.1%) | -$145.39 M(+4.9%) |
| Mar 2004 | - | -$45.21 M(+31.8%) | -$138.56 M(+13.0%) |
| Dec 2003 | -$122.58 M(+24.1%) | -$34.29 M(+15.2%) | -$122.58 M(+10.3%) |
| Sept 2003 | - | -$29.77 M(+1.6%) | -$111.13 M(+1.1%) |
| June 2003 | - | -$29.29 M(+0.2%) | -$109.90 M(+4.0%) |
| Mar 2003 | - | -$29.23 M(+28.0%) | -$105.67 M(+7.0%) |
| Dec 2002 | -$98.79 M(+18.3%) | -$22.84 M(-20.0%) | -$98.79 M(-7.4%) |
| Sept 2002 | - | -$28.54 M(+13.9%) | -$106.73 M(+7.1%) |
| June 2002 | - | -$25.06 M(+12.1%) | -$99.67 M(+8.4%) |
| Mar 2002 | - | -$22.35 M(-27.4%) | -$91.98 M(+10.2%) |
| Dec 2001 | -$83.48 M(+49.3%) | -$30.78 M(+43.2%) | -$83.49 M(+18.8%) |
| Sept 2001 | - | -$21.49 M(+23.7%) | -$70.25 M(+10.8%) |
| June 2001 | - | -$17.37 M(+25.4%) | -$63.37 M(+8.9%) |
| Mar 2001 | - | -$13.85 M(-21.0%) | -$58.21 M(+4.5%) |
| Dec 2000 | -$55.90 M(+49.5%) | -$17.54 M(+20.0%) | -$55.71 M(+19.4%) |
| Sept 2000 | - | -$14.62 M(+19.8%) | -$46.68 M(+10.7%) |
| June 2000 | - | -$12.20 M(+7.5%) | -$42.16 M(+4.7%) |
| Mar 2000 | - | -$11.36 M(+33.6%) | -$40.26 M(+7.6%) |
| Dec 1999 | -$37.40 M(+35.5%) | -$8.50 M(-15.8%) | -$37.40 M(+0.5%) |
| Sept 1999 | - | -$10.10 M(-1.9%) | -$37.20 M(+11.7%) |
| June 1999 | - | -$10.30 M(+21.2%) | -$33.30 M(+15.2%) |
| Mar 1999 | - | -$8.50 M(+2.4%) | -$28.90 M(+5.1%) |
| Dec 1998 | -$27.60 M(+7.8%) | -$8.30 M(+33.9%) | -$27.50 M(-3.5%) |
| Sept 1998 | - | -$6.20 M(+5.1%) | -$28.50 M(+4.8%) |
| June 1998 | - | -$5.90 M(-16.9%) | -$27.20 M(+1.1%) |
| Mar 1998 | - | -$7.10 M(-23.7%) | -$26.90 M(+4.7%) |
| Dec 1997 | -$25.60 M(+75.3%) | -$9.30 M(+89.8%) | -$25.70 M(+56.7%) |
| Sept 1997 | - | -$4.90 M(-12.5%) | -$16.40 M(+42.6%) |
| June 1997 | - | -$5.60 M(-5.1%) | -$11.50 M(+94.9%) |
| Mar 1997 | - | -$5.90 M | -$5.90 M |
| Dec 1996 | -$14.60 M | - | - |
FAQ
- What is CTI BioPharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for CTI BioPharma?
- What is CTI BioPharma annual EBIT year-on-year change?
- What is CTI BioPharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for CTI BioPharma?
- What is CTI BioPharma quarterly EBIT year-on-year change?
- What is CTI BioPharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for CTI BioPharma?
- What is CTI BioPharma TTM EBIT year-on-year change?
What is CTI BioPharma annual earnings before interest & taxes?
The current annual EBIT of CTIC is -$78.86 M
What is the all time high annual EBIT for CTI BioPharma?
CTI BioPharma all-time high annual earnings before interest & taxes is -$12.90 M
What is CTI BioPharma annual EBIT year-on-year change?
Over the past year, CTIC annual earnings before interest & taxes has changed by +$17.13 M (+17.85%)
What is CTI BioPharma quarterly earnings before interest & taxes?
The current quarterly EBIT of CTIC is -$8.37 M
What is the all time high quarterly EBIT for CTI BioPharma?
CTI BioPharma all-time high quarterly earnings before interest & taxes is $15.95 M
What is CTI BioPharma quarterly EBIT year-on-year change?
Over the past year, CTIC quarterly earnings before interest & taxes has changed by +$26.72 M (+76.14%)
What is CTI BioPharma TTM earnings before interest & taxes?
The current TTM EBIT of CTIC is -$52.13 M
What is the all time high TTM EBIT for CTI BioPharma?
CTI BioPharma all-time high TTM earnings before interest & taxes is -$5.90 M
What is CTI BioPharma TTM EBIT year-on-year change?
Over the past year, CTIC TTM earnings before interest & taxes has changed by +$61.88 M (+54.28%)